Evolution of Neuroendovascular Intervention: A Review of Advancement in Device Technology

Neurosurgery

Volumn 54, Issue 2, 2004, Pages 438-453

  Boulos, Alan S ^a   Levy, Elad I ^a   Bendok, Bernard R ^a   Kim, Stanley H ^a   Qureshi, Adnan I ^a   Guterman, Lee R ^a   Hopkins, L Nelson ^a   Higashida, Randall T ^b   Teitelbaum, George P ^b   Larsen, Donald W ^b   Rosenwasser, Robert H ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b NONE

Author keywords

Cerebrovascular disease; Embolization; Neuroendovascular surgery; Stents; Technology

Indexed keywords

ABCIXIMAB; ALTEPLASE; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR AFFECTING AGENT; FIBRINOLYTIC AGENT; HEPACOAT; HEPARIN; NITINOL; PACLITAXEL; POLITEF; PROUROKINASE; RAPAMYCIN; RECOMBINANT VASCULOTROPIN; RETEPLASE;

ANGIOPLASTY; ARTERIOVENOUS MALFORMATION; BRAIN ARTERY ANEURYSM; BRAIN ATHEROSCLEROSIS; BRAIN CIRCULATION; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEVICE; DRUG DOSE REDUCTION; DRUG ELUTING STENT; ENDARTERECTOMY; ENDOVASCULAR SURGERY; EXCIMER LASER; FUSIFORM ANEURYSM; HUMAN; INTRACRANIAL ANEURYSM; NEUROSURGERY; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; REVIEW; STENT; STROKE; SURGICAL INSTRUMENT; TECHNOLOGY; TREATMENT OUTCOME;

EID: 10744230673     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000103672.96785.42     Document Type: Review

References (0)